Primary Record
Tanespimycin
- In stock
- 6,917 g
- Purity
- 98.5 %
- CAS
- 75747-14-7
Compound Identifiers & Properties
- CAS
- 75747-14-7
- PubChem CID
- 6505803
- SMILES
- C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC
- Canonical SMILES
- C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O
Names & Synonyms
- Tanespimycin
- 17-AAG
- Telatinib
- tanespimycine
- 17-Allylaminogeldanamycin
- geldanamycin
- tanespimicina
- tanespimycinum
- 75747-14-7
- tanespimycina
- 17AAG
- 17-(Allylamino)geldanamycin
- 17-(Allylamino)-17-demethoxygeldanamycin
- Tanespimycin [USAN]
- KOS-953
- NSC-330507
- Tanespimycin (USAN)
- 17-AAG (Tanespimycin)
- 4GY0AVT3L4
- Tanespimycin [USAN:INN]
- UNII-4GY0AVT3L4
- RefChem:187385
- Tanespimycin (17-AAG)
- 17-allyl-aminogeldanamycin
- 17-allylamino-geldanamycin
- DTXSID5046352
- TANESPIMYCIN [INN]
- CHEBI:64153
- D0XV0T
- 17-(Allylamino) Geldanamycin
- AC1O6S9N
- CNF1010
- BMS-722782
- CCRIS 9401
- C31H43N3O8
- MFCD04973892
- 17-Demethoxy-17-allylamino geldanamycin
- BSPBio_001434
- DTXCID3026352
- CNF-1010
- NSC 330507
- TANESPIMYCIN [WHO-DD]
- NSC330507
- 17-AG
- CHEMBL109480
- GLD-36
- orb1300898
- SCHEMBL2604976
- Cp 127374
- CHEBI:94756
- CNF-101
- AYUNIORJHRXIBJ-TXHRRWQRSA-N
- GLXC-06825
- HMS1361H16
- HMS1791H16
- HMS1989H16
- HMS3402H16
- HMS6018C03
- 17-N-allylamino-17-demethoxygeldanamycin
- 17-allylamino-17-demethoxygeldanamycin
- EX-A4668
- NSC-330507D
- 17-demethoxy-17-(2-propenylamino)geldanamycin
- Tox21_112054
- BBF-04479
- BDBM50008057
- NCGC00163424-01
- s1141
- AKOS024456643
- C31-H43-N3-O8
- ZINC100014666
- AA17307
- BCP9000064
- CCG-208039
- CID6505803
- CS-0161
- DB05134
- Geldanamycin, 17-allylamino-17-demethoxy-
- Geldanamycin, 17-demethoxy-17-(2-propenylamino)-
- NSC-704057
- RL04887
- IDI1_033904
- NCGC00163424-02
- NCGC00163424-04
- NCGC00163424-05
- NCGC00163424-06
- NCGC00163424-07
- 17-allylamino-17-desmethoxy-geldanamycin
- Allylamino-17-demethoxygeldanamycin, 17-
- Geldanamycin, 17-(Allylamino)-17-demethoxy-
- HY-10211
- SC-22451
- 17-N-allylamino-17-demethoxy geldanamycin
- Geldanamycin, des-O-methyl-17-allylamino-
- 17-(allylamino)-17-demethoxy-geldanamycin
- AB2000717
- CAS-75747-14-7
- CP-127374
- FT-0630841
- X7553
- 17-ALLYLAMINO 17-DEMETHOXYGELDANAMYCIN
- A20594
- C76418
- D06650
- W-5317
- 747A147
- 2-Azabicyclo[16.3.1]docosane, geldanamycin deriv.
- A1-50460
- BRD-K81473043-001-03-9
- BRD-K81473043-001-08-8
- BRD-K81473043-001-14-6
- [(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate
- (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-(allylamino)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
- CP 127374, 75747-14-7
- 17-(Allylamino)-17-demethoxygeldanamycin, >=98% (HPLC), solid
- (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
- [(3S,5S,6R,7S,8E,10R,11S,12E,14E)-6-Hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-8,12,14,18,21-pentaen-10-yl] carbamate
- AAG
- 17-Demethoxy-17-allylaminogeldanamycin; Tanespimycin; 17-Allylaminogeldanamycin
- ((3R,5S,6R,7S,8E,10S,11S,12E,14E)-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo(16.3.1)docosa-1(21),8,12,14,18-pentaen-10-yl) carbamate
- ((4E,6E,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-enylamino)-2-azabicyclo(16.3.1)docosa-4,6,10,18,21-pentaen-9-yl) carbamate
- (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-Hydroxy-8,14-dimethoxy-4,10,12,16- tetramethyl-3,20,22-trioxo-19-(prop-2-enylamino)-2-azabicyclo(16.3.1)docosa- 1(21),4,6,10,18-penten-9-yl carbamate
- (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-Hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-penten-9-yl carbamate
- (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-[(prop-2-en-1-yl)amino]-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
- (8S,9S,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
- [(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-21-(allylamino)-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate
- [(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate
- [(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-(allylamino)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate
- 106-95-6
- 17-(Allylamino)geldanamycin; 17-Demethoxy-17-allylamino geldanamycin; 17-AAG; CP 127374; Geldanamycin,17-demethoxy-17-(2-propenylamino)-; NSC 330507; Tanespimycin
- 17-AAG|||17-(Allylamino)-17-demethoxy-geldanamycin|||[(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-6-Hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate